Table 4. Treatment burden according to... | American Society of Hematology

Table 4.

Treatment burden according to treatment phase

	Protocol Ia	Protocol Ib	Consolidation blocks	Protocol II, 1st	Protocol II, 2nd
No. patients analyzed	182	157	124	109	31
Red blood cells
Patients receiving at least 1 U, %	85	96	90	69	65
No. units, mean	2.9	3.1	3.7	2.4	2.1
Platelets
Patients receiving at least 1 U, %	51	36	70	16	23
No. units, mean	4.3	3.6	5.1	3.6	3.4
IV antibiotic therapy
Patients, %	46	37	82	46	74
Duration in days, mean	11	7	14	9	14
Central venous line
Patients, %	67	75	83	80	74
No. days, mean	35	50	68	74	78
Hospitalization
Patients, %	97	85	99	85	87
No. days, mean	22	14	32	11	19
Phase duration, days
Scheduled by protocol	42	42	63	64	64
Observed, mean	46	59	73	81	89

	Protocol Ia	Protocol Ib	Consolidation blocks	Protocol II, 1st	Protocol II, 2nd
No. patients analyzed	182	157	124	109	31
Red blood cells
Patients receiving at least 1 U, %	85	96	90	69	65
No. units, mean	2.9	3.1	3.7	2.4	2.1
Platelets
Patients receiving at least 1 U, %	51	36	70	16	23
No. units, mean	4.3	3.6	5.1	3.6	3.4
IV antibiotic therapy
Patients, %	46	37	82	46	74
Duration in days, mean	11	7	14	9	14
Central venous line
Patients, %	67	75	83	80	74
No. days, mean	35	50	68	74	78
Hospitalization
Patients, %	97	85	99	85	87
No. days, mean	22	14	32	11	19
Phase duration, days
Scheduled by protocol	42	42	63	64	64
Observed, mean	46	59	73	81	89

Mean values were estimated including only patients who actually required the specific support.

Consolidation blocks data presented pertain to the entire phase (3 blocks).

Central venous line data are cumulative.